MedTrace Logo

EFS of the CardioMech MVRS

NCT04820764 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2026-02-10

No results posted yet for this study

Summary

Safety and performance evaluation of the CardioMech Mitral Valve Repair System (MVRS) in patients with degenerative mitral valve regurgitation.

Conditions

  • Mitral Regurgitation

Interventions

DEVICE

CardioMech MVRS

CardioMech MVRS

Sponsors & Collaborators

  • CardioMech AS

    lead INDUSTRY

Principal Investigators

  • Mathew Williams, MD · NYU Langone

  • Mayra Guerrero, MD · Mayo Clinic

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-27
Primary Completion
2026-09-30
Completion
2031-09-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04820764 on ClinicalTrials.gov